Dupixent (Dupilumab),  is a monoclonal antibody designed for the treatment of allergic diseases such as eczema and asthma by blockage of IL-4Rα, dupilumab modulates signaling of both the interleukin 4 and interleukin 13 pathways, which are allergic pathways.

Indicated for 12 and older for asthma, contact our office if you are interested in a non-steroidal treatment for your child’s moderate to severe asthma.

CHANGES IN SHOT HOURS: 

Extended shot hours Monday, June 17th 1-5pm, Tuesday, June 18th extended til 5 pm, Monday, June 24th 1-5pm; Tuesday, June 25th til 5pm

Limited hours: Thursdays, June 20th 8:30-10:30am no afternoon hours,  Friday, June 21st 8:30-9:30am.     Tuesday, June 25th: no morning shot hours. 1-5:00pm only

Please follow us on Facebook for up to date changes and information.

At the recent AAAAI allergy national and international meeting in Orlando had many highlights including the late breaking news that AIMMUNE the company researching and producing the peanut oral immunotherapy showed that 67% of the patients being treated were able to tolerate 600mg (about 2 peanuts) without severe reaction! Hoping this treatment will be FDA approved by 2019 and on the market by 2019-2020! Finally an FDA safe and effective treatment for peanut allergic patients may be just around the corner.

Auvi Q 0.1 mg dose for infants less than 33 lbs will be available soon.

Call the office for your infant/toddler’s prescription. Must have been seen in last 6 months. (703) 558-6040.

For patients with dust mite allergy who are looking to lessen their dust mite allergy symptoms without medication should consider Odactra, a sublingual tablet of concentrated dustmite protein to help teach your body’s immune system to tolerate dust mites. The first dose is taken in the office and then at home! It’s covered by insurance plans. See if you are a candidate, call to make an appointment (703) 558-6040.

For infants at high risk, meaning they have eczema, food allergy, sibling with food allergy (especially peanut) or parents with allergies, the LEAP study showed that early introduction of peanut prevented a peanut allergy in most infants.

We offer an evaluation for these high-risk patients and if negative, then we can start patients safely on this preventative therapy and if borderline peanut reaction on allergy skin test, can offer a peanut challenge in the office.

Proper evaluation, dosing and frequency is important to make this therapy successful.

A positive allergy test alone does not determine a patient’s allergy status.  The size of skin test and/or level of specific IgE, the patient’s age, specific food and history all go into allowing a board-certified allergist to use their training to determine if a patient has a food allergy.  If needed, an oral challenge may be also utilized to help determine if a patient is truly allergic to a food an not unnecessarily avoiding a food. If your doctor does not offer an oral challenge as a possible option to determine your allergy status then they should not be testing you for allergies. Be educated, a fellowship trained board-certified allergist will be able to provide you the best possible allergy care.

https://reachmd.com/programs/what-your-patients-are-talking-about/companion-allergy-tests-limitations-effectiveness/9584/video/17101/

Winter is around the corner, Epiceram-L works great to help heal those dry cracked lips.

You can order it online at http://www.epiceram-us.com/epiceram-l

or on Amazon.com

Eucrisa is a new treatment for eczema. It is a PDE4 inhibitor. It blocks the inflammatory process involved in eczema. Come in and speak with the allergist to see if it’s right for you.

Indicated for ages 2 and older. Non-steroid medication. Copay cards available.